FDA plans to replace animal testing with AI – “Paradigm shift”

The requirement for animal testing in drug development will be phased out and replaced by AI, according to an announcement by the FDA. The decision has been met...

Cancer researcher: “We can do better and reduce suffering”

Lund University researcher Catharina Hagerling is developing innovative methods to understand metastatic cancer, aiming to create more targeted treatments for p...

Veteranen inom läkemedelsformulering: Mycket aktivitet i fältet

Korbinian Löbmann har flera gånger tidigare modererat New Updates in Drug Formulation & Bioavailability. Nu tar han åter sig an det vetenskapliga mötet.

Quality assurance for research and development of medical devices

Overcome the hurdles of research, development, and QA lab environments within the regulated medical technology industry.

ZEISS receives FDA clearance for INTRABEAM 700

With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy.

The Future of Swedish & Danish Life Science

ZEISS Quality Innovations at CONTROL

May 6-9, 2025 in Stuttgart.

Cost-efficient development of laboratory devices

8 ways to optimise development costs and speed up processes

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

From pharmacist to life science podcaster – Magnus Lejelöv uses his voice as a tool

Magnus Lejelöv has more than 20 years of experience in the pharmaceutical industry and has conducted nearly two hundred interviews with healthcare professionals...

Björn Arvidsson will lead research and innovation in Region Uppsala

The Swedish life science profile Björn Arvidsson has been appointed Director of Research and Innovation for Region Uppsala.

Europeiska läkemedelsaktier rasar efter Trumps tullhot

Europeiska läkemedelsbolag faller kraftigt efter att USA:s president Donald Trump flaggat för att stora tullhöjningar är på gång mot branschen.

Jazz anklagas för falskspel – går med på förlikning

Irländska Jazz Pharmaceuticals har gått med på att betala 145 miljoner dollar i förlikning efter anklagelser om brott mot amerikanska konkurrenslagar.

Sustainability at Festo

On the Way to the Net Zero Era - New Sustainability Report published

BMS gör nedskärningar på hemmaplan

Läkemedelsjätten Bristol Myers Squibb kapar bort 280 tjänster vid sina anläggningar i New Jersey och Kalifornien.

New Horizons in Biologics & Bioprocessing: Stockholm

Europeiska läkemedelsaktier faller inför Trumps tullbesked

Flera bolag inom den europeiska läkemedelssektorn sjunker på börsen inför kvällens tullbesked från USA.

Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

Norway rejects national life science strategy – sees no need

The Norwegian Arbeiderpartiet rejects a proposal that Norway should develop its own life science strategy.

Tau-targeted Alzheimer's drug gets Fast Track designation in the USA

Biogen's Alzheimer's candidate BIIB080 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

Misslyckande för BMS i sen studie om hjärtläkemedel

Läkemedelsjätten Bristol Myers Squibbs läkemedel mot en typ av hjärtsjukdom misslyckades i en sen klinisk studie. Det svaga utfallet ökar kraven på positiva utf...

The business coach: “We need to learn from our mistakes”

The past year has been challenging for many biotech companies, with several comapanies facing financial stress and bankruptcy. To understand how entrepreneurs c...